tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Liav Abraham, 55 are a BUY (77.46%), 14 are a HOLD (19.72%), 2 are a SELL (2.82%).
Analyst Liav Abraham works at CREDIT SUISSE with a stock forecast success ratio of 55.28% fulfilled within 298.08 days on average. Previously, Liav Abraham worked at CITI.
Liav Abraham’s has documented 150 price targets and ratings displayed on 12 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ELAN, Elanco Animal Health at 05-Aug-2021.
Analyst best performing recommendations are on INSM (INSMED).
The best stock recommendation documented was for TEVA (TEVA PHARMA INDUSTRIES LTD ADR) at 5/1/2018. The price target of $24 was fulfilled within 42 days with a profit of $5.29 (28.27%) receiving and performance score of 6.73.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
193
$-0.02 (-0.01%)
3 years 11 months 29 days ago
2/7 (28.57%)
$8.96 (4.87%)
35
Buy
203
4 years 2 months 1 days ago
1/2 (50%)
$20.22 (11.61%)
95
Hold
203
$9.98 (5.17%)
178
4 years 2 months 9 days ago
6/19 (31.58%)
$3.35 (1.68%)
69
Buy
247
4 years 8 months 12 days ago
0/4 (0%)
$88.31 (55.65%)
Hold
157
$-36.02 (-18.66%)
161
4 years 8 months 12 days ago
10/10 (100%)
$-1.84 (-1.16%)
200
What Year was the first public recommendation made by Liav Abraham?
